Mutations in the Voltage Sensors of Domains I and II of Nav1.5 that are Associated with Arrhythmias and Dilated Cardiomyopathy Generate Gating Pore Currents by Adrien Moreau et al.
ORIGINAL RESEARCH
published: 24 December 2015
doi: 10.3389/fphar.2015.00301
Edited by:
Hugues Abriel,
University of Bern, Switzerland
Reviewed by:
Stephan Kellenberger,
University of Lausanne, Switzerland
Peter Ruben,
Simon Fraser University, Canada
*Correspondence:
Mohamed Chahine
mohamed.chahine@phc.ulaval.ca
Specialty section:
This article was submitted to
Pharmacology of Ion Channels
and Channelopathies,
a section of the journal
Frontiers in Pharmacology
Received: 20 October 2015
Accepted: 09 December 2015
Published: 24 December 2015
Citation:
Moreau A, Gosselin-Badaroudine P,
Boutjdir M and Chahine M (2015)
Mutations in the Voltage Sensors
of Domains I and II of Nav1.5 that are
Associated with Arrhythmias
and Dilated Cardiomyopathy
Generate Gating Pore Currents.
Front. Pharmacol. 6:301.
doi: 10.3389/fphar.2015.00301
Mutations in the Voltage Sensors of
Domains I and II of Nav1.5 that are
Associated with Arrhythmias and
Dilated Cardiomyopathy Generate
Gating Pore Currents
Adrien Moreau1, Pascal Gosselin-Badaroudine1, Mohamed Boutjdir2 and
Mohamed Chahine1,3*
1 Centre de Recherche de l’Institut Universitaire en Santé Mentale de Québec, Quebec City, QC, Canada, 2 Cardiovascular
Research Program, VA New York Harbor Healthcare System, Brooklyn, NY, USA, 3 Department of Medicine, Université Laval,
Quebec City, QC, Canada
Voltage gated sodium channels (Nav) are transmembrane proteins responsible for action
potential initiation. Mutations mainly located in the voltage sensor domain (VSD) of
Nav1.5, the cardiac sodium channel, have been associated with the development of
arrhythmias combined with dilated cardiomyopathy. Gating pore currents have been
observed with three unrelated mutations associated with similar clinical phenotypes.
However, gating pores have never been associated with mutations outside the first
domain of Nav1.5. The aim of this study was to explore the possibility that gating
pore currents might be caused by the Nav1.5 R225P and R814W mutations (R3, S4
in DI and DII, respectively), which are associated with rhythm disturbances and dilated
cardiomyopathy. Nav1.5 WT and mutant channels were transiently expressed in tsA201
cells. The biophysical properties of the alpha pore currents and the presence of gating
pore currents were investigated using the patch-clamp technique. We confirmed the
previously reported gain of function of the alpha pores of the mutant channels, which
mainly consisted of increased window currents mostly caused by shifts in the voltage
dependence of activation. We also observed gating pore currents associated with
the R225P and R814W mutations. This novel permeation pathway was open under
depolarized conditions and remained temporarily open at hyperpolarized potentials after
depolarization periods. Gating pore currents could represent a molecular basis for the
development of uncommon electrical abnormalities and changes in cardiac morphology.
We propose that this biophysical defect be routinely evaluated in the case of Nav1.5
mutations on the VSD.
Keywords: SCN5A, gating pore current, arrhythmias, dilated cardiomyopathy, voltage sensor
INTRODUCTION
Voltage-gated sodium channels (Nav) are transmembrane proteins responsible for the initiation
and propagation of action potentials in many excitable cells. Cardiac action potentials are initiated
by Nav1.5, the main Nav isoform in the heart. This large 2016-amino-acid protein is encoded by
the SCN5A gene and is composed of 24 transmembrane segments organized in four homologous
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domains (Gellens et al., 1992). The assembly of the S5–S6
segments of each domain forms the alpha pore, which is
responsible for the selective permeation of Na+ ions that
underlies the physiological functions of the channel. The S1–
S4 segments of each domain make up the voltage sensor
domain (VSD), which modulates the activity of the channel
through conformational changes induced by variations in the
transmembrane voltage. Due to the crucial role of these channels
in the generation and regulation of the electrical signals,
dysfunctions result in pure arrhythmic phenotypes. For instance,
Nav1.5 dysfunctions result in cardiac pathologies such as Brugada
syndrome, type 3 Long QT syndrome, sick sinus syndrome, and
cardiac conduction disorders with no structural heart disease
(Amin et al., 2010).
Nav1.5 mutations have recently been linked to the
development of atypical phenotypes associating cardiac
arrhythmias and dilated cardiomyopathy (Bezzina et al., 2003;
McNair et al., 2011; Laurent et al., 2012; Mann et al., 2012; Nair
et al., 2012; Beckermann et al., 2014; Gosselin-Badaroudine
et al., 2014; Moreau et al., 2014a, 2015). The exact pathological
mechanism is not completely understood. While the clinical
phenotypes are similar, some mutations result in a gain of
channel function, some in a loss of channel function, and some
have no eﬀect on normal channel function (Bezzina et al., 2003;
Gosselin-Badaroudine et al., 2012b, 2014; Laurent et al., 2012;
Mann et al., 2012; Nair et al., 2012; Moreau et al., 2014a, 2015).
Two Nav1.5 mutations located at homologous positions on
the S4 segments of DI and DII (R225P and R814W; Figure 1)
have been characterized (Nguyen et al., 2008; Beckermann
et al., 2014). These mutations were found in patients whose
phenotypes feature complex arrhythmias associated with dilated
cardiomyopathy. Atrial ﬂutter and non-sustained ventricular
tachycardia were reported for the patient carrying the R814W
mutation (Olson et al., 2005). The patient Nav1.5 R225P
carrier experienced atrial and ventricular tachycardia, 2:1 atrio-
ventricular block, ventricular, atrial ectopy and prolonged QTc
(Beckermann et al., 2014). All carriers also demonstrate dilated
cardiomyopathy with reduced ventricular ejection fraction
(Olson et al., 2005; Beckermann et al., 2014). There is currently
no consensus on the exact pathological mechanism linking
morphological changes in the heart with a channel typically
associated with pure arrhythmic phenotypes.
Interestingly, most of the reported mutations (9 of 13) are
located on the positively charged S4 segment of the VSD (McNair
et al., 2011; Gosselin-Badaroudine et al., 2012b, 2014; Moreau
et al., 2014a, 2015). This segment drives the conformational
changes of the VSD in response to changes in voltage (Moreau
et al., 2014b). In the course of its movement, the positively
charged amino acids of the S4 segment sequentially interact with
their negatively charged counterparts on the S1–S3 segments
(Delemotte et al., 2011). This arrangement of negatively charged
amino acids on the S1–S3 segments is called the gating charge
transfer center (GCTC; Tao et al., 2010). Mutations of the
positively charged amino acids of the S4 segment disrupt
interactions between the S4 segment and the GCTC, resulting
in the creation of a new permeation pathway that passes directly
through the usually non-conductive VSD. This new permeation
pathway is called the gating pore (or omega pore; Sokolov et al.,
2005, 2007; Tombola et al., 2005; Struyk and Cannon, 2007;
Gosselin-Badaroudine et al., 2012a; Moreau et al., 2014a,b, 2015).
We hypothesized that gating pores might be a common
pathological mechanism of several VSD mutations linked to
cardiac arrhythmias and dilatation (Gosselin-Badaroudine et al.,
2014; Moreau et al., 2014a, 2015). We previously showed that the
R219H, R222Q, and R225W mutations in DI of the cardiac Na+
channel cause gating pore currents (Gosselin-Badaroudine et al.,
2012b; Moreau et al., 2015).
We used a heterologous expression system (tsA201 cells) to
study the R225P and R814W mutations (R3, S4 in DI and
DII, respectively; Figure 1; Nguyen et al., 2008; Beckermann
et al., 2014) to determine whether gating pores are present.
The characterization of both mutations conﬁrmed the previously
observed biophysical defects. We also showed that mutations in
DI and DII both result in gating pore currents.
We propose that this permeation pathway may participate
in the pathological mechanism. We further propose that this
pathway should be routinely evaluated in future studies on
SCN5A mutations in the VSD of the channel that are associated
with arrhythmias and dilated cardiomyopathy.
MATERIALS AND METHODS
Cell Culture
TsA201 cells, which are modiﬁed HEK-293 (human embryonic
kidney) cells stably transfected with simian virus 40 large
T antigen, were used for patch clamp experiments (Moreau
et al., 2012). The cells were cultured in high-glucose DMEM
supplemented with 10% fetal bovine serum (FBS), 2 mM
L-glutamine, 100 U/ml of penicillin G, and 10 mg/ml of
streptomycin (GIBCO- BRL Life Technologies, Canada) at 37◦C
in a 5% CO2 humidiﬁed atmosphere. The cells were transiently
transfected with WT or mutant Nav1.5 cDNA (5 μg) using the
calcium phosphate method as previously described (Deschenes
et al., 2000). The Nav1.5 α-subunit was co-transfected with the
human β1-subunit. Brieﬂy, 5 μg of each cDNA was mixed
with 500 μl of a 250 mM CaCl2 solution to which 500 μl of
HeBS2x (0.28 MNaCl, 0.05MHEPES, 1.5 MNa2HPO4, pH 7.05)
was added. Given the size of plasmids and genes inserted, we
transfected a ratio of 2 β1 subunits for each alpha subunits.
Patch-Clamp Recordings
Macroscopic Na+ currents (alpha currents) were recorded at
room temperature 48–72 h after transfection using the whole-
cell conﬁguration of the patch-clamp technique, as previously
described (Huang et al., 2011). The liquid junction potential
between the patch pipette and the bath solution were not
corrected. P/4 leak subtraction was only used for the alpha pore
current recordings. For the gating pore current recordings, linear
leak subtraction at hyperpolarized voltages was performed oﬀ-
line to eliminate the inherent non-speciﬁc leak. Currents were
recorded at a sampling rate of 83.33 kHz and were low pass
ﬁltered at 5 kHz. All currents were recorded using a pipette
solution composed of (in mM): 135 CsF, 5 NaCl, 10 EGTA, and
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FIGURE 1 | Location of the R225P and R814W mutations that target highly conserved residues in VSDs. (A) 2D structure of Nav1.5 channels showing the
24 TM segments organized into 4 domains (DI-DIV), each containing 6 TM. The S1-S4 segments of each domain form the VSD (light gray) while the assembly of the
S5–S6 segments (dark gray) form the pore of the channel. The locations of the R225P and R814W mutations are indicated by red circles. (B) 3D crystal structure of
the VSD of NavAb channel showing the residues that are conserved in all VSDs. These residues were determined by calculating the Shannon entropy at every
position for the 6,652 VSD sequence alignments reported by (Palovcak et al., 2014). Highly conserved residues are in blue while less conserved residues are in red.
The S1 segment was removed for purposes of clarity. The positively charged residues of the S4 segment (left) are highly conserved as are the residues forming the
GCTCs of the S2 and S3 segments (right and middle respectively).
10 HEPES (pH 7.4). The bath solution was composed of (in
mM): 115 NMDG, 20 NaCl, 2 CsCl, 2 Ca(OH)2, 10 HEPES,
and 10 TEA-Cl (pH 7.4). TEA-Cl was used to block endogenous
potassium currents. Niﬂumic acid (1 mM) freshly prepared in
100% ethanol was added to the bath solution to block endogenous
chloride channels before recording the gating pore currents.
When indicated, 10 μMTTX (Latoxan, France) was added to the
bath solution to block alpha pore currents.
Molecular Modeling
We used the procedure described by Moreau and coworkers to
generate models for the WT and mutated VSDs for both DI
and DII (Moreau et al., 2015). Brieﬂy, the high-resolution of
the pre-activated NavAb structure released in Payandeh et al.
(2011) in which all VSDs were considered to be in the activated
position was used as a template (accession code 3RVY). Standard
MODELER routines (Eswar et al., 2006) were used to generate
comparative models of the DI and DII VSDs of the Nav1.5
channels. Homologymodels in which the R225 andR814 residues
were in the GCTC were generated using a procedure described
previously (Wood et al., 2012; Moreau et al., 2015). Since the
activation/deactivation mechanism involves a sliding S4 helix
relative to a static S1-S3 bundle with discrete steps during
which the positive residues sequentially interact with the GCTC
(Delemotte et al., 2011; Gosselin-Badaroudine et al., 2012a;
Henrion et al., 2012; Jensen et al., 2012; Moreau et al., 2015). The
alignment of the S4 segments used for homology modeling was
shifted by three amino acids toward the C-terminus in order to
align R225 and R814 to the residue designated as K4 by Payandeh
et al. (2011). These alignments correspond to a meta-stable state
previously named β state (Delemotte et al., 2011). In this state,
R225 and R814 interact with the GCTC.
The homology models were then inserted in a POPC
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) bilayer and
were equilibrated under normal constant temperature and
pressure conditions (298 K, 1 atm.) in a 150 mM NaCl solution.
The lipid tails were melted during the ﬁrst nanosecond while
restraining the positions of the protein, the lipid head groups, the
water molecules, and the ions at their initial positions. Afterward,
only the protein was restrained for 2 ns. The restraints were
relaxed progressively for 6 ns. Lastly, a 100-ns unrestrained MD
simulation of the entire channel was conducted, enabling the
system to relax. The MD simulations were carried out using
the NAMD2 program. Langevin dynamics were applied to keep
the temperature (300 K) ﬁxed. The equations of motion were
integrated using a multiple time-step algorithm. Short- and
long-range forces were calculated every 1 and 2 time-steps,
respectively. The time steps were 2.0-fs long. The simulation used
the CHARMM22-CMAP force ﬁeld with torsional cross-terms
for the protein and CHARMM36 for the phospholipids.
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Mutant VSDs were created by introducing the mutation
into the equilibrated WT VSD using MODELER. They were
equilibrated using the same procedure. The simulations were
performed on the Calcul Québec/Compute Canada Colosse
supercomputer. The operation of the supercomputer is funded
by the Canada Foundation for Innovation (CFI), NanoQuébec,
RMGA, and the Fonds de recherche du Québec – Nature et
technologies (FRQ-NT).
Data Analysis and Statistics
The electrophysiological data were analyzed using Clampﬁt
(pCLAMP v10.0, Molecular Devices) and custom MATLAB
programs (The MathWorks, Inc.). Data are expressed as
mean ± SEM (standard error of the mean). When indicated, an
ANOVA with a Dunnett post hoc test or a t-test was performed.
Diﬀerences were considered signiﬁcant at a ∗P< 0.05, ∗∗P< 0.01,
or ∗∗∗P < 0.001.
RESULTS
The R225P and R814W Mutations Cause
a Gain of Function of the Alpha Current
As previously described (Nguyen et al., 2008; Beckermann et al.,
2014), the R225P and R814W mutations both induce a gain of
channel function. All experiments are presented in Figure 2while
in Table 1 all values and number of independent experiments are
listed (Figure 2 andTable 1). However, the defects induced by the
R814W mutation were less pronounced than that of the R225P
mutation. Both mutations increased the opening probability at
hyperpolarized voltages [left shift of their half voltage (V1/2) of
activation, increased slope parameter]. R225P mutant channels
displayed a larger slope factor for their steady-state inactivation
curve while R814W mutant channels displayed a left shift in the
V1/2 of inactivation. Both mutations produced a slower recovery
from inactivation, an increase in time to peak, and a slow current
decay. These alterations in the biophysical properties of the
channel resulted in an increase in channel function through an
increase in the window current as well as an increase in channel
availability as evidenced by the calculated open probability and
the ramp currents (Figure 2).
The R225P and R814W Mutations both
Create Gating Pores that are Activated at
Depolarized Potentials
Gating pores are an alternative permeation pathway created in
the usually non-conductive VSDs of voltage-gated ion channels
by the disruption of interactions between the S4 segment and
the GCTC (Moreau et al., 2014a,b, 2015). Due to the nature and
location of the R225P and R814W mutations (R3 and S4 in DI
and DII, respectively), we hypothesized that they might generate
gating pore currents. Unlike WT channels, gating pore currents
were induced by the R225P and R814W mutations when 80-ms
voltage steps ranging from −100 to +40 mV in 5 mV increments
were applied. Because P/4 leak subtraction was not used to record
the gating pore currents, linear leak subtraction at hyperpolarized
voltages, when gating pores should be closed, was performed oﬀ-
line to eliminate the non-speciﬁc leak inherent to the patch-clamp
method (Figure 3, bottom panels). The gating pore currents
created by the R225P mutation were larger than those created
by the R814W mutation [at +40 mV: 11.8 ± 1.0 pA/pF for
R225P (n = 5), 3.4 ± 0.4 pA/pF for R814W (n = 4), and
0.4 ± 0.2 pA/pF for WT (n = 4); Figure 4]. Tetrodotoxin (TTX),
an alpha pore blocker, did not modify the gating pore currents
induced by the R225P [at +40 mV: 11.8 ± 1.0 pA/pF (n = 5)
without TTX vs. 10.9 ± 1.1 pA/pF (n = 6) with 10μMTTX] and
R814W mutant channels [at +40 mV 3.4 ± 0.4 pA/pF (n = 4)
without TTX vs. 3.2 ± 0.3 pA/pF (n = 3) with 10 μM TTX;
Figure 4B]. This conﬁrmed that these cation leak currents do not
ﬂow through the alpha pore of the channel but rather through an
alternative pathway created by the mutations. The gating pores
investigated here were activated by membrane depolarizations.
The normalized gating pore currents (I/Imax) showed that the
R225P and R814W gating pores have similar voltage dependence
(Figure 4C).
Mutations at the bottom of the S4 segment near the cytoplasm
amplify the naturally occurring S4 segment immobilization
due to long depolarization periods (Sokolov et al., 2008; Fan
et al., 2013; Groome et al., 2014; Moreau et al., 2014b, 2015).
Gating pore currents were thus recorded (in the presence
of 10 μM TTX) using a ramp protocol ranging from −140
to 0 mV at 0.72 mV/ms after a 500-ms pre-depolarization
to +40 mV and were compared to those elicited by the
same ramp protocol without pre-depolarization (see protocol
shown as inset in Figure 5). To minimize the impact of
capacitance artifacts, gating pore currents were measured from
−135 to 0 mV. The I/V curves were constructed by averaging
current values every 5 mV. After linear leak subtraction,
gating pore currents at hyperpolarized potentials were observed
only after a 500-ms pre-depolarization for both mutants [at
−135 mV: −4.6 ± 0.8 pA/pF (n = 6) vs. −0.3 ± 0.1 pA/pF
(n = 5) without pre-depolarization for R225P channels and
−2.6 ± 0.4 pA/pF (n = 4) vs. −0.4 ± 0.2 pA/pF (n = 4)
for R814W channels]. As expected, no currents were recorded
with WT channels (−0.8 ± 0.1 pA/pF, n = 5) with a 500-ms
pre-depolarization.
DISCUSSION
Nav1.5 mutations are involved in pure electrical disorders
such as Brugada syndrome, type 3 long QT syndrome, and
cardiac conduction defects with no structural heart diseases
(Amin et al., 2010; Moreau et al., 2012, 2013). However,
SCN5A mutations have been recently associated with cardiac
dysfunctions combining arrhythmias and dilatation (McNair
et al., 2011; Moreau et al., 2014a). How this gene could be at
the origin of a structural heart disease is not fully understood.
Gating pores are alternative permeation pathways created in
the VSDs of ion channels by the disruption of interactions
between the GCTC and the S4 segment (Moreau et al., 2014b).
These gating pores notably appear as a result of mutations
of the charged residues of the S4 segment. Such pores are
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FIGURE 2 | Biophysical characterization of the Nav1.5 mutant channels. The values for the Nav1.5 WT channel are indicated by black symbols, those for the
R225P mutant channel by orange symbols, and those for the R814W mutant channel by green symbols. (A) Representative whole-cell current traces of the WT and
mutant channels (see protocol in inset). (B) Current density-voltage (I–V) relationships of the WT and mutant channels. (C) Voltage-dependence of steady-state
activation of the WT and mutant channels. Activation curves were generated using a standard Boltzmann distribution [G(V )/Gmax = 1/(1+exp(-(V−V1/2 )/k))] and
gave the V1/2 and k values listed in Table 1. (D) Steady state inactivation of the WT and mutant channels (see protocol in inset). The recorded inactivation values
were fitted to a standard Boltzmann equation [I(V )/Imax = 1/(1+exp((V−V1/2 )/k))+C] and gave the values listed in Table 1. (E) Recovery from fast inactivation values
were obtained using a two-pulse protocol at +30 mV to obtain maximal activation (see protocol in inset). The time constants listed in Table 1 were obtained using a
single-exponential function: (Afast x (1 – exp(-t/τfast )) + C). (F) The times to peak of the WT and mutant channels were used to evaluate activation kinetics. The times
to peak were measured from the same current traces used to construct the I-V relationship (A). (G) The time constants of fast inactivation decay were plotted as a
function of voltage for the WT and mutant channels. The time constants were obtained using a simple-exponential function: (A x (exp(-t/τ) + C). Normalized raw data
shown in the inset illustrate the current decay kinetics. (H) The overlap between activation and inactivation defines the window current. The predicted window current
was obtained using the following equation: (1/(1 + exp((V1/2activation – V)/kactivation)) x ((1 – C)/(1 + exp((V – V1/2inactivation)/kinactivation )) + C). (I) Ramp protocols (see
protocol in inset) were imposed (0.64 mV/ms) to study the window current. Ramp current traces were normalized to the alpha peak current. (J) Histogram showing
the peak window current normalized to the alpha peak current (% of peak current). ∗Difference vs. Nav1.5/WT using ANOVA (∗∗∗P < 0.001).
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TABLE 1 | Biophysical parameters of Nav1.5/WT, R225P, and R814W.
WT (n = 7) R225P (n = 8) R814W (n = 9)
Peak current
(pA/pF)
−154.4 ± 37.4 −303.8 ± 62.5∗ −151.8 ± 23.8
Activation
V1/2 (mV) −44.1 ± 1.9 −50.6 ± 1.0∗∗ −49.6 ± 1.3∗
k (mV) −6.9 ± 0.6 −10.1 ± 0.3∗∗∗ −9.4 ± 0.3∗∗∗
Inactivation
V1/2 (mV) −88.6 ± 0.7 −89.2 ± 1.9 −91.0 ± 0.8∗
k (mV) 4.6 ± 0.2 5.3 ± 0.2∗ 4.9 ± 0.2
Recovery from
inactivation
τ (ms) 2.2 ± 0.1 3.0 ± 0.2∗∗ 3.2 ± 0.2∗∗∗
Peak ramp current
(% peak current)
6.4 ± 0.7 29.0 ± 2.7∗∗∗ 16.5 ± 1.7∗∗
V1/2, Mid point for activation or inactivation.
K, Slope factor for activation or inactivation.
∗Difference vs. Nav1.5/WT using ANOVA (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).
known to be permeant to cations with a selectivity sequence
that is more permissive for larger ions (Moreau et al., 2014a,b,
2015).
Several mutations on the S4 segment of the Nav1.5
channel have been studied due to their association with
the pathological development of arrhythmias and dilated
cardiomyopathy (Bezzina et al., 2003; Nguyen et al., 2008;
Laurent et al., 2012; Mann et al., 2012; Nair et al., 2012;
Beckermann et al., 2014; Moreau et al., 2014a, 2015). However,
no consensus has emerged on the pathological process leading
to this atypical clinical phenotype. In addition, some mutations
with similar clinical phenotypes cause diﬀerent biophysical
defects (gain or loss of function; Nguyen et al., 2008; Gosselin-
Badaroudine et al., 2014; Moreau et al., 2014a, 2015). We
propose that gating pore currents may be a common pathological
mechanism linking all mutations on the VSDs of the Nav1.5
channel (Gosselin-Badaroudine et al., 2012b, 2014; Moreau et al.,
2014a, 2015). We previously showed that gating pore currents
are generated by three mutations found in unrelated patients
(R219H, R222Q, and R225W) that cause complex arrhythmias
and dilated cardiomyopathy (Gosselin-Badaroudine et al., 2012b;
Moreau et al., 2015). All these mutations are located in the S4
segment of DI of the Nav1.5 channel. The creation of gating pores
due to mutations in the DII of the Nav1.5 channel has never
been investigated before. Such investigations remain of critical
importance, because the association between a mutation and the
creation of a gating pore cannot be only based on its location.
Mutations on Nav1.4 DI, DII, and DIII VSDs have been shown
to cause the creation of a gating pore. Against all expectations,
similar mutations on DIV VSD do not create a gating pore.
This diﬀerence appears to be related to a larger hydrophobic
septum in this particular VSD (Gosselin-Badaroudine et al.,
2012a). Oppositely, the study of the similar DIV VSD of Cav1.1
channels has clearly shown that mutations in this domain create
gating pores (Fan et al., 2013). Nevertheless, given the high
sequence homology between Nav1.4 and Nav1.5, the creation of
gating pores due to mutations in Nav1.5 DI, DII, or DIII VSD’s
is expected. While single mutations on Nav1.5 DI, Nav1.4 DI,
and Nav1.4 DII VSDs have been shown to open a gating pore
(Gosselin-Badaroudine et al., 2012a,b; Moreau et al., 2015), other
studies revealed that multiple mutations are required to create
a gating pore in Nav1.2 DII or in the Shaker VSD (Sokolov
et al., 2005; Gamal El-Din et al., 2010). All together, these results
FIGURE 3 | Gating pore currents of the Nav1.5 R225P and R814W mutant channels. Gating pore currents were recorded in absence of TTX. The cells were
held at −100 mV and currents were recorded using a voltage-step protocol from −100 to +40 mV in 5 mV increments. The top panels show examples of raw traces
of gating pore currents. The currents are plotted as a function of voltage in the bottom panels. Linear non-specific leaks are indicated by dotted lines.
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FIGURE 4 | Voltage dependence of gating pore currents. (A) Current
density-voltage relationships of gating pore currents recorded for the WT,
R225P, and R814W channels are shown as filled symbols in the absence of
TTX (n = 5 for R225P, n = 4 for R814W, and n = 4 for WT channels) and as
empty symbols in the presence of 10 μM TTX (n = 6 for R225P, n = 3 for
R814W, and n = 5 for WT channels). (B) Histograms summarizing the gating
pore current densities at +40 mV for the WT, R225P, and R814W channels
(0.4 ± 0.2 pA/pF, 11.8 ± 1.0 pA/pF, and 3.4 ± 0.4 pA/pF, respectively). No
differences were observed with or without TTX for any of the conditions.
(C) Normalized gating pore currents (I/Imax ) exhibiting similar voltage
dependence for both the R225P and R814W mutant channels. ∗Difference vs.
Nav1.5/WT (∗∗∗P < 0.001).
clearly demonstrate that caution is warranted to conclude that
a mutation creates or not a gating pore based on its location in
the VSD.
We report that gating pores are caused by two other recently
characterized mutations, R225P and R814W, which are located
in DI and DII, respectively, of Nav1.5 (Figure 1). We previously
studied the R222Q and R225W Nav1.5 DI VSD mutations
(Moreau et al., 2015). Besides the creation of gating pores due to
both mutations, several biophysical defects were also recorded.
This study notably reports an increase (R222Q) or a decrease
(R225W) in current density and hyperpolarized (R222Q) or
depolarized (R225W) shifts in the steady state activation. Thus,
biophysical defects of R222Q pointed toward a gain of function
while defects of R225W mutants indicated a loss of channel
function (Moreau et al., 2015). Unlike the R225W mutation,
the R225P and R814W mutations both cause a gain of channel
function, although the defect is less pronounced with the R814W
mutant. Gating pores created by these mutations are activated by
membrane depolarizations. Interestingly, the biophysical defects
observed for alpha pore currents should also aﬀect gating pore
currents. The left shift of steady state activation should indicate
an early movement of the VSD, resulting in an early opening
of the gating pore. Nevertheless, the voltage dependence of
the activation is a complicated process resulting from both the
movement of the VSD and the coupling between the VSD and
the pore domain. The correlation between the alpha pore voltage
dependence of activation and the movement of a VSD is thus not
necessarily direct. Here, both steady state activation curves were
left shifted (Table 1). This could be due to an earlier movement of
the VSD or a tighter coupling between the VSD and the PD. In the
case of an earlier movement of the VSD, this would result in an
earlier opening of the gating pore. In our previous study of R222Q
and R225W, the voltage dependence of R222Q gating pore was
slightly left shifted when compared to the voltage dependence
of the R225W gating pore (Moreau et al., 2015). This result
would indicate that shifts in the voltage dependence of alpha
pore currents would be due to diﬀerences in the mutants’ VSDs
movement. Indeed, the voltage dependence of the alpha pore
current of the R222Q mutant was importantly hyperpolarized
when compared with the voltage dependence of the alpha pore
current of the R225Wmutant (Moreau et al., 2015).
The gating pores currents generated by the R225P and
R814W mutations were recorded using Cs+ due to its higher
permeability. However, based on previously reported selectivity
sequences for gating pores, K+ and Na+ are highly expected
to permeate this pathological pore and should aﬀect electrical
signals and ionic homeostasis (Moreau et al., 2014a,b, 2015).
Like other depolarization-activated gating pores (Sokolov et al.,
2008; Fan et al., 2013; Groome et al., 2014; Moreau et al.,
2015), the gating pores created by the R225P and R814W
mutations remained open after long periods of depolarization,
probably due to the temporary partial freezing of the S4 segment
(Gamal El-Din et al., 2014; Moreau et al., 2014b). Given the
physiological ion concentrations on both sides of the membrane
and the biophysical properties of these gating pores, the pores
should cause outward K+ and Na+ leaks under depolarized
conditions (during the action potential plateau phase) and
inward Na+ leak at the end of each action potential (Moreau
et al., 2014a,b, 2015). Gating pore currents constitute small
leak currents opened as soon as the voltage sensor has moved
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FIGURE 5 | Gating pore currents after long depolarizations. (A) Currents generated by ramp pulses (see protocols in inset) for the WT (left), R225P (middle),
and R814W (right) channels. The I–V curves were constructed by averaging current values every 5 mV. Voltages were calculated using the known time course of the
ramp protocol. A linear leak subtraction around −75 to −45 mV was performed to eliminate the inherent linear leak. The insets show the currents in response to the
ramp protocols. Dashed lines indicate the current obtained without pre-depolarization while solid lines indicate the response after a 500-ms pre-depolarization at
+40 mV. (B) Histogram summarizing the inward gating pore current density at −135 mV recorded with or without a 500-ms pre-depolarization. ∗ Indicates a
statistical difference between the condition with or without pre-depolarization tested using a t-test (∗∗P < 0.01); # Indicates differences with the WT channel (with the
500-ms pre-depolarization) tested using an ANOVA. (#P < 0.05, ###P < 0.001) .
(Moreau et al., 2014a,b, 2015). Considering their small amplitude,
their contribution to the pathologic mechanism could thus be
questioned. Nevertheless, it is now well-accepted that small late
Nav1.5 currents can cause the LQT3 syndrome (Ruan et al.,
2009; Amin et al., 2010). Although gating pore currents or
late currents are of small amplitude, they are opened for long
durations. Consequently, their impact would probably be related
to the continuous stress imposed to cardiac myocytes. Several
pathological consequences of gating pores have been described
in the case of Nav1.4 mutations associated with the development
of hypokalemic periodic paralysis (HypoPP). In this case, an
important elevation of the resting membrane potential (VRest) is
thought to be the cause of clinical manifestations (Rudel et al.,
1984; Jurkat-Rott et al., 2009). Cation leaks due to gating pores
usually represent 1–6% of the alpha pore current amplitude
(Moreau et al., 2014a,b). Consequently, charges ﬂowing through
the gating pores are thought to not be enough to cause this
elevation in VRest . This VRest elevation would most probably be
related to the ionic homeostasis imbalance (intracellular Na+ and
Ca2+ overload) caused by the gating pore. The ionic homeostasis
imbalance would block ion channels such as Kir channels
and thus cause the VRest elevation (Hughes and Swaminathan,
2008; Struyk and Cannon, 2008; Tricarico and Camerino, 2011;
Moreau et al., 2014a). A similar process is thus expected to aﬀect
patient’s cardiac myocytes, resulting in a potentially pathological
depolarization of their VRest. This ionic homeostasis imbalance
could then result in several other pathological consequences
such as the block of connexins, impair the excitation-contraction
coupling or also the function and the assembly of contractile
proteins (Fabiato and Fabiato, 1978; Chandra et al., 1999;
Stergiopoulos et al., 1999; Bukauskas et al., 2001; Duﬀy et al.,
2004; Feng et al., 2008; Moreau et al., 2014a). Taken together,
these defects could result in the atypical clinical phenotype
associating DCM and mixed arrhythmias. Furthermore, the
pathological potential of such gating pore currents is strongly
strengthened by the association of a similar mutation in Nav1.4
(R1135C/H, R3 – S4, DIII) associated with HypoPP phenotype
(Groome et al., 2014).
The R225P and R814Wmutations should disrupt interactions
between the S4 segment and the GCTC. Based on previously
published results (Moreau et al., 2014a,b, 2015), these two
mutations should also aﬀect the structure of the VSD, allowing
the merging of water crevices as illustrated in Figure 6. Once
the water crevices merge, a new permeation pathway appears
through the usually non-conductive VSD structure, allowing ions
to permeate. The substitution of the arginine by a tryptophan
(R814W) causes a major impediment to the S4 structure and its
movement, resulting in a twist of the segment due to the aﬃnity
of tryptophan for lipid tails. The substitution of the arginine by a
proline (R225P) should also cause a major modiﬁcation of the
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FIGURE 6 | Molecular basis for the creation of gating pores. (A) Models of the DI and DII of Nav1.5 were built based on previously published results (Moreau
et al., 2015). The top row shows the DI models. The bottom row shows the DII models. The left panels represent WT VSDs and the right panels represent mutant
VSDs (top R225P, bottom R814W). The protein is shown as orange ribbons, and the water crevice is shown in blue. Positively charged residues in the S4 segment
and residues making up the GCTC are highlighted. Positively charged residues are depicted in blue, negatively charged residues in red, aromatic residues in yellow,
and the proline in gray. The complete VSD is shown (left) for each panel. A higher magnification of the GCTC is also shown to clearly see the interactions between
the S4 segment and the GCTC (middle) as well as the merging of the water crevices from both sides of the membrane (right) for the mutant channels. For purposes
of clarity, the S1 segment has been removed. (B) Water density profiles of the Nav1.5/DI (orange) – DII (green) WT and R225P – R814W mutant channels (dash
lines). The histograms were built using a 1-A grid, and the averages were calculated from at least 6 ns of the trajectories. 0 corresponds to the position of the Cα of
Y168 of S2 (DI) or the position of the Cα of F760 of S2 (DII).
S4 structure. While other reported mutations mainly result in
modiﬁcations to the side chain of the amino acid, the substitution
by a proline aﬀects both the side chain and the alpha carbon.
Due to these modiﬁcations and based on previously published
results, the creation of a continuous water wire through the VSD
would thus underlie the creation of gating pores in DI and DII
of Nav1.5 channels. Indeed, although extensive perturbations to
the VSD structure such as the ones possibly induced by the
proline and the tryptophan may be hard to resolve in the 100
ns time, our models show that the mutant VSDs are potentially
permeable to ions. The water density proﬁle was assessed by
counting the average occupancy of water molecules in the VSD
along the z-axis (perpendicular to the membrane) over 6 ns
(Figure 6B). For both mutants the hydrophobic septa (volumes
that are not accessible to water) are drastically shorter and more
hydrated than the corresponding WT VSDs. In contrast with our
previous study (Moreau et al., 2015), along very few angstroms,
the water accessible volume in the R225P and R814W VSDs
is below one water molecule but clearly above 0. These results
more likely indicate that in some frames, no water molecules can
be found, while in other frames at the same location a water
molecule is found. Since the water density proﬁle is built on
at least 600 frames, the mean value is neither 0 nor above 1.
This behavior was not observed in WT VSDs as they featured
constriction sites in which the water proﬁle value was 0 over
several angstroms. Finally, consistently with both our previous
study and our experimental data, these results would indicate
that R225P and R814W mutated VSDs can conduct ions due
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to hydrophobic septum disruption resulting in water crevices
junction.
Further investigation is also required concerning VSD
mutations located outside the S4 segment. Indeed, mutations in
S1–S3 segments are known to be associated with the development
of arrhythmias and dilated cardiomyopathy (McNair et al., 2004,
2011; Olson et al., 2005; Nguyen et al., 2008; Moreau et al.,
2014a; Swan et al., 2014). The creation of a gating pore due
to such mutations has never been investigated. Nevertheless,
mutations in the VSD but outside the S4 segment might also
disrupt interactions between the S4 segment and the GCTC and
thus cause the creation of a gating pore.
Gating pores are now well-accepted to be also involved in
the pathological development of other muscular or neuronal
disorders (periodic paralysis and peripheral nerve hyper-
excitability; Sokolov et al., 2007, 2008; Struyk and Cannon,
2007; Miceli et al., 2012; Moreau et al., 2014a). The exact
pathological downstream consequences of these cation leaks in
myocytes require further exploration. Patient speciﬁc induced
pluripotent stem cells (hiPSC) or transgenic mouse models
could thus constitute models of choice to further investigate
the pathologic potential of these leak currents and clearly study
their pathologic importance. Nevertheless, we hypothesize that
such leaks unbalance ionic homeostasis, thus impairing electrical
signals, cellular communication, and excitation-contraction
coupling (Moreau et al., 2014a, 2015). The combination of gating
pores and defects of the alpha pore could thus lead to the atypical
clinical phenotype observed.
CONCLUSION
Our study identiﬁed gating pores induced by two unrelated
Nav1.5 mutations. This is the ﬁrst time that amutation generating
a gating pore outside the DI of Nav1.5 has been investigated.
The R225P and R814W mutations both caused an atypical
clinical phenotype associating cardiac arrhythmia with dilatation,
bringing the number of known mutations that create gating
pores related to this clinical phenotype to ﬁve. Given that the
alpha pores of several mutated channels are also defective,
gating pores likely contribute to the pathogenesis rather than
cause it. However, the presence of these gating pores may
determine whether the mutations result in a pure electrical
disorder or a pathology associating electrical and morphological
abnormalities. We thus propose that gating pores that are
created by Nav1.5 mutations on the VSD and that are associated
with combined electrical and morphological cardiac pathologies
should be investigated as a biophysical defect. Finally, while
this biophysical characterization is a prerequisite to the better
understanding of the pathogenesis, future studies of transgenic
animals are warranted for the comprehension of the link between
gating pore current and the clinical phenotype combining
complex arrhythmias and DCM.
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